Children's Hospital Zhejiang

Company snapshot

浙江大学医学院附属儿童医院 is a company based out of China.

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Children's Hospital Zhejiang. Not investment advice.

• What is Children's Hospital Zhejiang?

  Children's Hospital of is a pharma organization headquartered in CN. Primary therapeutic focus areas include BPD - Bronchopulmonary Dysplasia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials

• Is Children's Hospital Zhejiang publicly traded?

  Children's Hospital Zhejiang appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Children's Hospital Zhejiang develop or market?

  We link 2 drug profile(s) where Children's Hospital Zhejiang is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/the-children-s-hospital-of-zhejiang-university-school-of-medicine#company-drugs.

• What are the latest developments for Children's Hospital Zhejiang?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Children's Hospital Zhejiang focus on?

  Children's Hospital Zhejiang focuses on BPD - Bronchopulmonary Dysplasia based on our analysis of their pipeline programs and drug development activities.